Harbin Jixianglong Biotech Co., Ltd.
2
Recalls
0
Units Recalled
0
Injuries
0
Deaths
1 category · 2026-03-11 to 2026-03-11
| Date | Source | Product | Brand | Severity | Units |
|---|---|---|---|---|---|
| 2026-03-11 | FDA Drug | FDA Recall: Semaglutide, For Rx compounding use only, packaged in a) 1g, NDC 84385-106-01; b) 5g, NDC 84385-106 | Harbin Jixianglong Biotech Co., Ltd. | Class II | N/A |
| 2026-03-11 | FDA Drug | FDA Recall: Semaglutide, For Rx compounding use only, packaged in a) 1g, NDC 84385-106-01; b) 5g, NDC 84385-106- | Harbin Jixianglong Biotech Co., Ltd. | Class II | N/A |